The parent compounds of the ceramide family, composed of sphingosine having an unspecified fatty acyl group attached to the nitrogen.
ChEBI ID: 52639
Member | Definition | Role |
---|---|---|
2,3-n-octanoylsphingosine | An N-acylsphingosine in which the ceramide N-acyl group is specified as octanoyl. | N-octanoylsphingosine |
n-(7-(4-nitrobenzo-2-oxa-1,3-diazole))-6-aminocaproyl sphingosine | An N-acylsphingosine that is sphingosine with the amino nitrogen converted into a 6-{[N-(7-nitrobenzo-2,1,3-oxadiazol-4-yl)amino]}hexananamido group. | N-{6-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]hexanoyl}sphingosine |
n-acetylsphingosine | A N-acylsphingosine that has an acetamido group at position 2. | N-acetylsphingosine |
n-caproylsphingosine | An N-acylsphingosine consisting of sphing-4-enine bearing a hexanoyl group on nitrogen. | N-(hexanoyl)sphing-4-enine |
n-palmitoylsphingosine | A N-acylsphingosine in which the ceramide N-acyl group is specified as hexadecanoyl (palmitoyl). | N-hexadecanoylsphingosine |
Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
---|---|---|
pre-1990 | 5 (0.63) | 18.7374 |
1990's | 221 (27.69) | 18.2507 |
2000's | 368 (46.12) | 29.6817 |
2010's | 170 (21.30) | 24.3611 |
2020's | 34 (4.26) | 2.80 |
Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 7 (0.82%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 848 (99.18%) | 84.16% |